Celldex Therapeutics, Inc

(NASDAQ:CLDX)

Latest On Celldex Therapeutics, Inc (CLDX):

Date/Time Type Description Signal Details
2023-05-18 18:33 ESTNewsCelldex Therapeutics: Revolutionizing Cancer Care With Innovative ImmunotherapiesN/A
2023-05-04 23:29 ESTNewsCelldex GAAP EPS of -$0.62, revenue of $1MN/A
2023-03-02 14:39 ESTNewsCelldex Therapeutics (CLDX) Presents At AAAAI ConferenceN/A
2023-02-28 18:15 ESTNewsCelldex GAAP EPS of -$0.56 beats by $0.03, revenue of $1.61M beats by $1.35MN/A
2023-02-27 12:59 ESTNewsCelldex gains 12% on Phase 1 data for urticaria candidateN/A
2023-02-20 07:02 ESTNewsCelldex: Long List Of Failures, High Valuation, But Good Data RecentlyN/A
2022-12-02 20:42 ESTNewsCelldex: Shares Continue To Rally On Barzolvolimab Hope (Technical Analysis)N/A
2022-11-09 22:05 ESTNewsCelldex GAAP EPS of -$0.57 beats by $0.01, revenue of $0.41M beats by $0.05MN/A
2022-08-09 00:09 ESTNewsCelldex Non-GAAP EPS of -$0.59 misses by $0.17, revenue of $0.16M misses by $0.24MN/A
2022-07-22 13:36 ESTNewsCelldex begins dosing in mid-stage study of barzolvolimab for skin disorderN/A
2022-07-14 20:11 ESTNewsCelldex: Barzolvolimab Plus Bispecific Antibodies AdvancementN/A
2022-07-01 20:44 ESTNewsCelldex posts early-stage data to support dose-dependent effect of urticaria therapyN/A
2022-05-06 00:47 ESTNewsCelldex GAAP EPS of -$0.49 misses by $0.04, revenue of $0.17M misses by $0.39MN/A
2022-03-01 04:31 ESTNewsCelldex GAAP EPS of -$0.43 misses by $0.02, revenue of $0.33M misses by $0.84MN/A
2022-03-01 04:31 ESTNewsCelldex Therapeutics, Inc. (CLDX) CEO Anthony Marucci on Q4 2021 Results - Earnings Call TranscriptN/A
2022-03-01 04:31 ESTNewsCelldex Therapeutics, Inc. 2021 Q4 - Results - Earnings Call PresentationN/A
2022-02-28 08:33 ESTNewsCelldex Q4 2021 Earnings PreviewN/A
2022-02-17 13:49 ESTNewsCelldex Therapeutics (CLDX) Investor Presentation - SlideshowN/A
2022-02-01 06:48 ESTNewsCelldex: Pipeline Of Drug Candidates Is Worth A LookN/A
2021-11-12 18:41 ESTNewsCelldex posts preclinical data from CDX-585 PD-1/ILT4 bispecific antibody programN/A
2021-11-10 04:54 ESTNewsCelldex EPS misses by $0.09, misses on revenueN/A
2021-09-29 12:19 ESTNewsCelldex's CDX-0159 improves quality of life and reduced disease impact in urticaria patientsN/A
2021-09-24 01:18 ESTNewsCelldex Therapeutics: A Best Price-Positioned Biotech Stock As Seen By Market-MakersN/A
2021-08-06 00:09 ESTNewsCelldex EPS beats by $0.06, beats on revenueN/A
2021-07-22 20:52 ESTNewsCelldex rises with bullish call from Guggenheim; potential of lead asset citedN/A
2021-07-21 00:15 ESTNewsCelldex: Powerful Medicines To Yield Further UpsidesN/A
2021-07-21 00:14 ESTNewsCelldex gains over a third on early-stage data for CDX-0159 in skin conditionN/A
2021-07-21 00:13 ESTNewsAnimal health ratings change at Guggenheim; Celldex up with positive views on trial data - today’s analyst actionN/A
2021-07-21 00:13 ESTNewsTempest Therapeutics, Xtant Medical leads healthcare gainers; Sigilon Therapeutics, TransMedics among major losersN/A
2021-07-21 00:12 ESTNewsCelldex Therapeutics proposes $175M capital raiseN/A
2021-07-21 00:12 ESTNewsCelldex's Latest Data For Chronic Inducible Urticaria Drug Is Only The BeginningN/A
2021-07-21 00:10 ESTNewsCelldex Therapeutics raises $250M via equity offeringN/A
2021-05-07 05:42 ESTNewsCelldex EPS misses by $0.08, misses on revenueN/A
2021-03-30 03:43 ESTNewsCelldex EPS misses by $0.18, beats on revenueN/A
2021-03-29 08:13 ESTNewsCelldex reports 80% complete response rate in CDX-0159 study in skin allergyN/A
2021-03-02 07:24 ESTAnalyst RatingThe Analyst Target Price has increased from $30.67 to $34.33.Buy
2021-02-24 03:23 ESTAnalyst RatingThe Analyst Target Price has increased from $26.33 to $30.67.Buy
2021-02-22 18:38 ESTNewsCelldex to expand development of CDX-0159 into prurigo nodularisN/A
2021-01-17 17:51 ESTNewsCelldex: New Monoclonal Therapeutic Line, 1Q21's CDX-0159's Initial Trial Data, And MoreN/A
2020-12-13 03:34 ESTFinancialsCompany financials have been released.Neutral
2020-12-09 15:50 ESTNewsDosing underway in Celldex's CDX-0159 study in skin allergyN/A
2020-11-19 19:29 ESTAnalyst RatingThe Analyst Target Price has increased from $23.5 to $26.33.Buy
2020-11-10 03:27 ESTFinancialsCompany financials have been released.Neutral
2020-11-09 03:34 ESTAnalyst RatingThe Analyst Target Price has increased from $21.5 to $23.5.Buy
2020-11-07 15:24 ESTFinancialsCompany financials have been released.Neutral
2020-11-06 19:23 ESTEarnings EstimateAn EPS average of -$0.38 is estimated for the quarter ending on March 31, 2021.Sell
2020-11-06 04:46 ESTNewsCelldex EPS in-line, beats on revenueN/A
2020-11-01 17:32 ESTFinancialsCompany financials have been released.Neutral
2020-10-30 12:32 ESTAnalyst RatingThe Analyst Target Price has increased from $17 to $21.5.Buy
2020-10-14 09:13 ESTNewsDosing underway in Celldex Therapeutics' CDX-0159 early-stage skin disorder studyN/A

About Celldex Therapeutics, Inc (CLDX):

Celldex Therapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of immunotherapies and other cancer-targeting biologics. It develops CDX-1140, an agonist human monoclonal antibody, which is being studied as a single-agent and in combination with CDX-301 in a Phase I dose-escalation study in metastatic solid tumors and B cell lymphomas; CDX-3379, a monoclonal antibody designed to block the activity of ErbB3 that is in an early Phase II study in advanced head and neck squamous cell cancer in combination with Erbitux; CDX-0159, a Phase I monoclonal antibody that binds the KIT receptor and inhibits its activity; and CDX-527, a bispecific antibody that uses anti-PD-L1 and CD27 human antibodies to couple CD27 co-stimulation with blockade of the PD-L1/PD-1 pathway. The company also holds exclusive rights to CDX-301 and CD40 ligand, which are immune modulating molecules that increase the numbers and activity of immune cells that control immune responses. Celldex Therapeutics, Inc. has research collaboration and license agreements with University of Southampton; Amgen Inc.; Yale University; and MedImmune, LLC. The company was incorporated in 1983 and is headquartered in Hampton, New Jersey.

CLDX Quotes by TradingView

See Advanced Chart

General

  • Name Celldex Therapeutics, Inc
  • Symbol CLDX
  • Type Common Stock
  • Exchange NASDAQ
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryBiotechnology
  • Full Time Employees 127
  • Last Split Factor1:15
  • Last Split Date2019-02-11
  • Fiscal Year EndDecember
  • IPO Date2008-03-10
  • Gic SectorHealth Care
  • Gic GroupPharmaceuticals, Biotechnology & Life Sciences
  • Gic IndustryBiotechnology
  • Gic SubIndustryBiotechnology
  • Web URLhttp://www.celldex.com
View More

Valuation

  • Price/Sales (Trailing 12 Mt.) 133.88
  • Price/Book (Most Recent Quarter) 4.37
  • Enterprise Value Revenue 186.73
  • Enterprise Value EBITDA 0.01
View More

Financials

  • Most Recent Quarter 2020-09-30
  • Next Quarter EPS Estimate -$0.38
  • Operating Margin -1150%
  • Return on Assets -17%
  • Return on Equity -29%
  • Revenue 4.52 million
  • Earnings Per Share -$3.74
  • Revenue Per Share $0.19
  • Gross Profit -39099000
  • Quarterly Earnings Growth 22.3%
View More

Highlights

  • Market Capitalization 988.78 million
  • EBITDA -51311000
  • PE Ratio -18.24
  • Analyst Target Price $34.33
  • Book Value Per Share $5.81
View More

Share Statistics

  • Shares Outstanding 39.57 million
  • Shares Float 28.85 million
  • % Held by Insiders 16%
  • % Held by Institutions 82.07%
  • Shares Short 2.87 million
  • Shares Short Prior Month 3.44 million
  • Short Ratio 4.18
  • Short % of Float 7%
  • Short % of Shares Outstanding 7%
View More

Technicals

  • Beta 2.73
  • 52 Week High $30.17
  • 52 Week Low $1.51
  • 50 Day Moving Average 25.2
  • 200 Day Moving Average 18.9
View More

Dividends

  • Dividend Date 2019-02-11
  • ExDividend Date N/A
  • Dividend Yield 0%
View More

Celldex Therapeutics, Inc (CLDX) Dividend Calendar:

CLDX's last dividend payment was made to shareholders on February 11, 2019.

Ex-Dividend Date Payment Date Record Date Declared Date Amount

Celldex Therapeutics, Inc (CLDX) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2020-09-302020-11-05$668000-$0.36-$0.360%
2020-06-302020-08-06$N/A-$0.50-$0.5813.79%
2020-03-312020-05-06$2.73 million-$0.73-$0.70-4.29%
2019-12-312020-03-26$887000-$0.64-$0.9331.18%
2019-09-302019-11-12$546000-$0.75-$0.8410.71%
2019-06-302019-08-07$715000-$0.84-$1.1728.21%
2019-03-312019-05-07$1.43 million-$1.40-$1.14-22.81%
2018-12-312019-03-07$1.76 million-$0.81-$1.2032.5%
2018-09-302018-11-07$941000-$0.60-$2.2573.33%
2018-06-302018-08-08$2.76 million-$1.65-$2.5535.29%
2018-03-312018-05-10$4.07 million-$12.60-$3.03-315.84%
2017-12-312018-03-07$3.46 million-$0.45-$3.7387.92%
2017-09-302017-11-07$3.92 million-$3.00-$3.9824.53%
2017-06-302017-08-08$3.83 million-$3.45-$4.0915.71%
2017-03-312017-05-09$1.53 million-$4.20-$4.281.75%
2016-12-312017-03-14$1.87 million-$4.50-$5.0510.89%
2016-09-302016-11-07$2.22 million-$4.35-$4.9712.42%
2016-06-302016-08-08$1.39 million-$4.80-$5.054.95%
2016-03-312016-05-05$1.3 million-$5.25-$5.24-0.29%
2015-12-312016-02-23$1.79 million-$4.95-$5.204.81%
2015-09-302015-11-05$1.03 million-$0.32-$0.358.57%
2015-06-302015-08-10$2.18 million-$0.33-$0.342.94%
2015-03-312015-04-29$486000-$0.33-$0.368.33%
2014-12-312015-02-24$1.48 million-$0.36-$0.35-2.86%
2014-09-302014-11-05$1.1 million-$0.31-$0.336.06%
2014-06-302014-08-06$592000-$4.80-$4.840.83%
2014-03-312014-05-01$416000-$4.95-$3.94-25.63%
2013-12-312014-03-03$620000-$4.05-$4.183.11%
2013-09-302013-11-08$980000-$4.35-$3.66-18.85%
2013-06-302013-08-06$97000-$3.60-$3.34-7.78%
2013-03-312013-05-02$2.41 million-$3.45-$3.30-4.55%
2012-12-312013-03-07$3.65 million-$4.05-$3.75-8%
2012-09-302012-11-01$3.11 million-$3.75-$3.62-3.59%
2012-06-302012-08-10$2.01 million-$3.45-$3.798.97%
2012-03-312012-05-03$2.43 million-$4.05-$3.57-13.45%
2011-12-312012-03-07$2.43 million-$4.35-$4.17-4.32%
2011-09-302011-11-02$2.36 million-$4.05-$3.84-5.47%
2011-06-302011-08-03$1.95 million-$4.05-$4.295.59%
2011-03-312011-05-04$2.52 million-$4.65-$4.54-2.42%
2010-12-312011-03-03$2.13 million-$3.60$3.15-214.29%
2010-09-302010-11-02$2.41 million-$4.35-$4.8710.68%
2010-06-302010-08-04$2.95 million-$4.50-$3.95-13.92%
2010-03-312010-05-04$3.71 million-$3.15-$3.9520.25%
2009-12-312010-03-04$4.73 million-$6.45-$4.30-50%
2009-09-302009-11-04$4.03 million-$6.75-$8.3218.87%
2009-06-302009-08-05$2.69 million-$8.25-$7.10-16.2%
2009-03-312009-05-05$3.73 million-$7.35-$6.90-6.52%
2008-12-312009-02-27$2.99 million-$7.05-$8.1012.96%
2008-09-302008-11-05$2.36 million-$7.50-$7.20-4.17%
2008-06-302008-08-06$1.96 million-$10.05-$8.40-19.64%
2008-03-312008-05-19$147000-$32.85-$9.97-229.49%
2007-12-312008-02-27$384000-$26.19
2007-09-302007-10-31$269000-$12.60-$12.600%
2007-06-302007-08-02$609000-$12.60-$18.0030%
2007-03-312007-05-03$144000-$87.35
2006-12-312007-03-07$255000-$14.40-$14.400%
2006-09-302006-11-01$199000-$14.40-$12.60-14.29%
2006-06-302006-08-02$317000-$14.40-$12.60-14.29%
2006-03-312006-05-09$128000-$7.20-$5.40-33.33%
2005-12-312006-03-08$36000-$9.00-$10.8016.67%
2005-09-302005-10-27$23000-$10.80-$12.6014.29%
2005-06-302005-08-03$12000-$10.80-$6.30-71.43%
2005-03-312005-05-05$N/A-$12.60-$11.70-7.69%
2004-12-312005-03-02-$9.00-$10.8016.67%
2004-09-302004-10-20-$8.98
2004-06-302004-07-22-$9.00-$9.000%
2004-03-312004-04-21-$5.40-$9.0040%
2003-12-312004-02-24-$9.00-$9.000%
2003-09-302003-10-22-$5.40-$10.8050%
2003-06-302003-07-23-$9.48
2003-03-312003-04-30-$10.01
2002-12-312003-02-26-$10.80-$12.6014.29%
2002-09-302002-10-23-$1.80-$16.2088.89%
2002-06-302002-07-24-$16.20-$17.105.26%
2002-03-312002-04-24-$14.40-$18.0020%
2001-12-312002-02-26-$19.80-$20.402.94%
2001-09-302001-10-25-$19.80-$23.4015.38%
2001-06-302001-08-02-$18.00-$22.8021.05%
2001-03-312001-04-25-$12.60-$16.2022.22%
2000-12-312001-03-01-$14.40-$13.50-6.67%
2000-09-302000-10-25-$12.60-$12.600%
2000-06-302000-06-30-$9.79
2000-03-312000-04-27-$7.20-$10.8033.33%
1996-12-311997-02-19-$16.20-$18.0010%
1996-09-301996-11-06-$18.00-$18.000%
1996-06-301996-07-23-$39.60-$18.00-120%
1995-12-311996-02-27-$28.80-$25.20-14.29%
1995-09-301995-11-10-$32.40-$27.00-20%
1995-06-301995-08-11-$27.00-$25.20-7.14%
1995-03-311995-05-12-$25.20-$23.40-7.69%
1994-12-311995-02-15-$19.80-$35.1043.59%
1994-09-301994-11-10-$23.40-$24.303.7%
1994-06-301994-08-02-$23.40-$25.207.14%
1994-03-311994-05-02-$19.80-$25.2021.43%
1993-09-301993-10-29-$27.00-$21.60-25%
1993-03-311993-05-12-$23.40-$18.00-30%

Celldex Therapeutics, Inc (CLDX) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date
Research Development
Income Before Tax
Selling General Administrative
Gross Profit
Ebit
Operating Income
Income Tax Expense
Total Revenue
Cost of Revenue
Total Other Income Expense Net
Net Income From Continuing Operations
Net Income Applicable to Common Shares
Cash Flow:
Date
Investments
Change to Liabilities
Total Cash Flow from Investing Activities
Net Borrowings
Total Cash Flow from Financial Activities
Change to Operating Activities
Change in Cash
Total Cash from Operating Activities
Depreciation
Other Cash Flow from Investing Activities
Change to Inventory
Change to Account Receivables
Other Cash Flow from Financing Activities
Change to Net Income
Capital Expenditures
Balance Sheet:
Date
Total Liabailities
Total Stockholder Equity
Other Current Liabilities
Total Assets
Common Stock
Other Current Assets
Retained Earnings
Other Liabilities
Other Assets
Cash
Total Current Liabilities
Other Stockholder Equity
Property, Plant & Equipment
Total Current Assets
Long Term Investments
Net Tangible Assets
Short Term Investments
Long Term Debt
Inventory
Accounts Payable

Celldex Therapeutics, Inc (CLDX) Chart:

Celldex Therapeutics, Inc (CLDX) News:

Below you will find a list of latest news for Celldex Therapeutics, Inc (CLDX) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

Celldex Therapeutics, Inc (CLDX) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent
2025-04-17130CALL0 0115.38TRUE00
2025-04-17140CALL0 0144.24TRUE00
2025-04-17150CALL0 0133.44TRUE00
2025-04-17160CALL0 054.82TRUE00
2025-04-17170CALL0 051.14TRUE00
2025-04-17183.1CALL0 1193.08TRUE00
2025-04-17190CALL0 0109.06TRUE00
2025-04-17200CALL0 086.22FALSE00
2025-04-17212.05CALL0 2076.89FALSE00
2025-04-17220.35CALL0 26459.67FALSE00
2025-04-17230.54CALL0 565.85FALSE00
2025-04-17240.7CALL0 1175.45FALSE00
2025-04-17251.65CALL0 183.64FALSE00
2025-04-17260CALL0 0105.29FALSE00
2025-04-17270CALL0 0114.86FALSE00
2025-04-17280CALL0 0118.87FALSE00
2025-04-17290CALL0 0118.76FALSE00
2025-04-17300CALL0 0255.87FALSE00
2025-04-17350CALL0 0249.2FALSE00
2025-04-17130PUT0 0180.31FALSE00
2025-04-17140PUT0 0126.25FALSE00
2025-04-17150PUT0 0134.75FALSE00
2025-04-17160PUT0 088.8FALSE00
2025-04-17170PUT0 080.25FALSE00
2025-04-17180.4PUT0 1068.68FALSE00
2025-04-17191.45PUT0 154.13FALSE00
2025-04-17202.13PUT0 21106.83TRUE00
2025-04-17210PUT0 033.74TRUE00
2025-04-17222.68PUT0 187.7TRUE00
2025-04-17230PUT0 063.44TRUE00
2025-04-17240PUT0 075.09TRUE00
2025-04-17250PUT0 085.76TRUE00
2025-04-17260PUT0 077.05TRUE00
2025-04-17270PUT0 0187.09TRUE00
2025-04-17280PUT0 082.07TRUE00
2025-04-17290PUT0 0121.75TRUE00
2025-04-17300PUT0 0163.63TRUE00
2025-04-17350PUT0 0222.39TRUE00
2025-05-16100CALL0 0123.84TRUE00
2025-05-1612.50CALL0 0216.71TRUE00
2025-05-16140CALL0 087.65TRUE00
2025-05-16150CALL0 070.73TRUE00
2025-05-16160CALL0 089.56TRUE00
2025-05-1617.58CALL0 199.63TRUE00
2025-05-16192.7CALL0 4076.5TRUE00
2025-05-16208CALL0 1102.24FALSE00
2025-05-16211.35CALL0 13105.74FALSE00
2025-05-1622.51.09CALL0 2578.82FALSE00
2025-05-16240.8CALL0 5379FALSE00
2025-05-16250.52CALL0 4470.18FALSE00
2025-05-16260.65CALL0 165.68FALSE00
2025-05-16270.5CALL0 174.55FALSE00
2025-05-16283.54CALL0 17875.84FALSE00
2025-05-16290.3CALL0 11106.36FALSE00
2025-05-16300.75CALL0 116109.58FALSE00
2025-05-16310CALL0 090.83FALSE00
2025-05-16320CALL0 0186.87FALSE00
2025-05-16330CALL0 0192.3FALSE00
2025-05-16340CALL0 095.86FALSE00
2025-05-16350.2CALL2 34195FALSE0.20
2025-05-16360CALL0 0103.26FALSE00
2025-05-16370CALL0 0106.75FALSE00
2025-05-16380CALL0 0110.11FALSE00
2025-05-16390CALL0 0119.93FALSE00
2025-05-16400.1CALL0 147116.49FALSE00
2025-05-16450.05CALL0 3792.01FALSE00
2025-05-16500.5CALL0 46164.87FALSE00
2025-05-16551.25CALL0 2271.94FALSE00
2025-05-16600CALL0 0163.58FALSE00
2025-05-16650CALL0 0136.27FALSE00
2025-05-16100PUT0 0140.07FALSE00
2025-05-1612.50PUT0 0104.37FALSE00
2025-05-16140.35PUT0 186.36FALSE00
2025-05-16150.45PUT0 178.93FALSE00
2025-05-16160PUT0 077.6FALSE00
2025-05-1617.51.35PUT0 889.47FALSE00
2025-05-16190PUT0 074.01FALSE00
2025-05-16202.05PUT0 2192.91TRUE00
2025-05-16210PUT0 066.28TRUE00
2025-05-1622.53.7PUT0 5958.12TRUE00
2025-05-16240PUT0 095.88TRUE00
2025-05-16254.6PUT0 5946.46TRUE00
2025-05-16260PUT0 066.27TRUE00
2025-05-16274.87PUT0 17872.46TRUE00
2025-05-16280PUT0 0134.73TRUE00
2025-05-16290PUT0 0156.56TRUE00
2025-05-16309.3PUT0 57377.55TRUE00
2025-05-16310PUT0 0108.89TRUE00
2025-05-16320PUT0 0102.02TRUE00
2025-05-16330PUT0 0131.71TRUE00
2025-05-16340PUT0 0103.75TRUE00
2025-05-16350PUT0 0111.7TRUE00
2025-05-16360PUT0 0122.71TRUE00
2025-05-16370PUT0 0123.25TRUE00
2025-05-16380PUT0 0130.52TRUE00
2025-05-16390PUT0 0143.83TRUE00
2025-05-164013.3PUT0 0144.4TRUE00
2025-05-16450PUT0 0170.41TRUE00
2025-05-16500PUT0 0155.82TRUE00
2025-05-16550PUT0 0162.93TRUE00
2025-05-16600PUT0 0173.87TRUE00
2025-05-16650PUT0 0194.07TRUE00
2025-08-15100CALL0 092.65TRUE00
2025-08-15130CALL0 088.67TRUE00
2025-08-15140CALL0 087.69TRUE00
2025-08-15150CALL0 088.42TRUE00
2025-08-15160CALL0 083.88TRUE00
2025-08-1517.510.2CALL0 176.84TRUE00
2025-08-15190CALL0 079.65TRUE00
2025-08-15204.9CALL0 4169.66FALSE00
2025-08-15213.71CALL0 10070.13FALSE00
2025-08-1522.54.5CALL0 15074.61FALSE00
2025-08-15240CALL0 088.24FALSE00
2025-08-15251.7CALL0 1076.11FALSE00
2025-08-15265.8CALL0 169.23FALSE00
2025-08-15273.6CALL0 478.01FALSE00
2025-08-15281.9CALL0 1068.53FALSE00
2025-08-15292.5CALL0 1371.65FALSE00
2025-08-15301.3CALL0 2071.39FALSE00
2025-08-15311.05CALL0 1180.31FALSE00
2025-08-15320.74CALL0 177.73FALSE00
2025-08-15332.1CALL0 087.74FALSE00
2025-08-15342CALL0 288.72FALSE00
2025-08-15351.8CALL0 791.45FALSE00
2025-08-15360CALL0 095.37FALSE00
2025-08-15372.3CALL0 180.76FALSE00
2025-08-15380CALL0 089.23FALSE00
2025-08-15390CALL0 192.95FALSE00
2025-08-15401CALL0 167.67FALSE00
2025-08-15100PUT0 0118.39FALSE00
2025-08-15130PUT0 085.4FALSE00
2025-08-15141.05PUT1 479.55FALSE1.050
2025-08-15151.3PUT1 1377.24FALSE1.30
2025-08-15161.7PUT0 682.66FALSE00
2025-08-1517.51.95PUT0 1085.63FALSE00
2025-08-15192.1PUT0 180.54FALSE00
2025-08-15203.3PUT1 470.24TRUE3.30
2025-08-15213.9PUT0 478.63TRUE00
2025-08-1522.54.5PUT0 377.18TRUE00
2025-08-15240PUT0 073.11TRUE00
2025-08-15255.7PUT0 151276.51TRUE00
2025-08-15260PUT0 065.16TRUE00
2025-08-15270PUT0 062.5TRUE00
2025-08-15280PUT0 064.06TRUE00
2025-08-15296.6PUT0 169.19TRUE00
2025-08-15307.3PUT0 172.84TRUE00
2025-08-15310PUT0 072.11TRUE00
2025-08-15320PUT0 057.45TRUE00
2025-08-15330PUT0 066.86TRUE00
2025-08-15340PUT0 071.55TRUE00
2025-08-15350PUT0 070.26TRUE00
2025-08-15360PUT0 076.88TRUE00
2025-08-15370PUT0 077.42TRUE00
2025-08-15380PUT0 090.59TRUE00
2025-08-15390PUT0 091.41TRUE00
2025-08-15400PUT0 086.48TRUE00
2025-11-21100CALL0 084.94TRUE00
2025-11-21120CALL0 067.36TRUE00
2025-11-21130CALL0 082.87TRUE00
2025-11-21140CALL0 078.09TRUE00
2025-11-21150CALL0 068.82TRUE00
2025-11-21160CALL0 066.24TRUE00
2025-11-21170CALL0 068.89TRUE00
2025-11-21180CALL0 074.03TRUE00
2025-11-21190CALL0 075.52TRUE00
2025-11-21200CALL0 070.58FALSE00
2025-11-21210CALL0 073.43FALSE00
2025-11-21220CALL0 076.11FALSE00
2025-11-21230CALL0 072.8FALSE00
2025-11-21240CALL0 066.8FALSE00
2025-11-21250CALL0 073.71FALSE00
2025-11-21260CALL0 064.17FALSE00
2025-11-21270CALL0 068.9FALSE00
2025-11-21280CALL0 072.6FALSE00
2025-11-21300CALL0 079.42FALSE00
2025-11-21350CALL0 081.26FALSE00
2025-11-21100PUT0 086.82FALSE00
2025-11-21120PUT0 098.66FALSE00
2025-11-21130PUT0 093.57FALSE00
2025-11-21140PUT0 095.92FALSE00
2025-11-21150PUT0 068.16FALSE00
2025-11-21160PUT0 080.62FALSE00
2025-11-21172.6PUT0 175.21FALSE00
2025-11-21183.1PUT0 172.38FALSE00
2025-11-21190PUT0 057.78FALSE00
2025-11-21204.1PUT0 155.01TRUE00
2025-11-21210PUT0 068.4TRUE00
2025-11-21220PUT0 072.58TRUE00
2025-11-21230PUT0 062.09TRUE00
2025-11-21240PUT0 054.18TRUE00
2025-11-21250PUT0 060.13TRUE00
2025-11-21260PUT0 065.77TRUE00
2025-11-21270PUT0 071.15TRUE00
2025-11-21280PUT0 067.22TRUE00
2025-11-21300PUT0 067.46TRUE00
2025-11-21350PUT0 066.13TRUE00
2025-12-1950CALL0 0141.1TRUE00
2025-12-1980CALL0 077.83TRUE00
2025-12-19100CALL0 077.37TRUE00
2025-12-1912.58.9CALL0 3585.11TRUE00
2025-12-19150CALL0 075.89TRUE00
2025-12-1917.510.2CALL0 1868.99TRUE00
2025-12-19204.79CALL0 1670.25FALSE00
2025-12-1922.53.65CALL0 3666.94FALSE00
2025-12-19254.8CALL0 3366.81FALSE00
2025-12-19276.12CALL0 564.49FALSE00
2025-12-19302CALL0 31963.46FALSE00
2025-12-19321.7CALL0 20063.36FALSE00
2025-12-19351.13CALL0 2364.32FALSE00
2025-12-19370CALL0 065.6FALSE00
2025-12-19403CALL0 857.9FALSE00
2025-12-19450.45CALL0 1965.99FALSE00
2025-12-19501.55CALL0 4167.23FALSE00
2025-12-19551.25CALL0 770.42FALSE00
2025-12-19601.05CALL0 1587.06FALSE00
2025-12-19650.8CALL0 2895.73FALSE00
2025-12-1950PUT0 0117.59FALSE00
2025-12-1980PUT0 0104.39FALSE00
2025-12-19100PUT0 088.78FALSE00
2025-12-1912.51.4PUT0 1181.12FALSE00
2025-12-19152PUT0 1090.26FALSE00
2025-12-1917.52.5PUT0 2381.48FALSE00
2025-12-19204.1PUT0 271.43TRUE00
2025-12-1922.53.3PUT0 465.75TRUE00
2025-12-19256PUT0 564.29TRUE00
2025-12-19270PUT0 067.2TRUE00
2025-12-193011.35PUT1 106165.43TRUE11.350
2025-12-19320PUT0 069.09TRUE00
2025-12-19350PUT0 064.64TRUE00
2025-12-19370PUT0 067.68TRUE00
2025-12-194013.2PUT0 565.39TRUE00
2025-12-19450PUT0 067.6TRUE00
2025-12-19500PUT0 078.8TRUE00
2025-12-19550PUT0 091.79TRUE00
2025-12-19600PUT0 097.74TRUE00
2025-12-19650PUT0 096.29TRUE00

Latest CLDX Trades:

Date Shares Price
Jun 13, 2022 7:59 PM EST2$20.54
Jun 13, 2022 7:59 PM EST61$20.52
Jun 13, 2022 7:59 PM EST28$20.52
Jun 13, 2022 7:59 PM EST1$20.51
Jun 13, 2022 7:59 PM EST190$20.54

Celldex Therapeutics, Inc (CLDX) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2020-06-26SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/744218/000092189520001867/0000921895-20-001867-index.htm
2018-02-06SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/744218/000003877718000054/0000038777-18-000054-index.htm
2018-07-10SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/744218/000021545718005851/0000215457-18-005851-index.htm
2018-02-13SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/744218/000031506618001108/0000315066-18-001108-index.htm
2018-05-10SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/744218/000031506618001910/0000315066-18-001910-index.htm
2020-07-24SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/744218/000090266420002780/0000902664-20-002780-index.htm
2020-06-26SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/744218/000092189520001867/0000921895-20-001867-index.htm
2018-02-09SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/744218/000093247118003136/0000932471-18-003136-index.htm
2019-02-11SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/744218/000093247119004430/0000932471-19-004430-index.htm
2020-10-22SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/744218/000093583620000571/0000935836-20-000571-index.htm
2020-02-12SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/744218/000103738920000083/0001037389-20-000083-index.htm
2018-03-0710-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/744218/000104746918001363/0001047469-18-001363-index.htm
2018-04-19PRE 14AOther preliminary proxy statementshttps://www.sec.gov/Archives/edgar/data/744218/000104746918002964/0001047469-18-002964-index.htm
2018-04-30DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/744218/000104746918003326/0001047469-18-003326-index.htm
2019-03-0710-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/744218/000104746919000992/0001047469-19-000992-index.htm
2019-04-26DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/744218/000104746919002607/0001047469-19-002607-index.htm
2019-12-06S-3Registration statement under Securities Act of 1933https://www.sec.gov/Archives/edgar/data/744218/000104746919006714/0001047469-19-006714-index.htm
2020-03-2610-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/744218/000104746920001809/0001047469-20-001809-index.htm
2020-04-28DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/744218/000104746920002644/0001047469-20-002644-index.htm
2020-06-12424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/744218/000104746920003564/0001047469-20-003564-index.htm
2020-06-15424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/744218/000104746920003601/0001047469-20-003601-index.htm
2020-06-15424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/744218/000104746920003602/0001047469-20-003602-index.htm
2020-06-17424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/744218/000104746920003646/0001047469-20-003646-index.htm
2018-04-248-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/744218/000110465918026170/0001104659-18-026170-index.htm
2018-05-1010-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/744218/000110465918031972/0001104659-18-031972-index.htm
2018-06-018-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/744218/000110465918037447/0001104659-18-037447-index.htm
2018-06-148-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/744218/000110465918040165/0001104659-18-040165-index.htm
2018-08-0810-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/744218/000110465918050496/0001104659-18-050496-index.htm
2018-11-0710-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/744218/000110465918066648/0001104659-18-066648-index.htm
2018-11-278-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/744218/000110465918070024/0001104659-18-070024-index.htm
2018-12-108-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/744218/000110465918072097/0001104659-18-072097-index.htm
2019-02-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/744218/000110465919006667/0001104659-19-006667-index.htm
2019-05-07DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/744218/000110465919027504/0001104659-19-027504-index.htm
2019-05-0710-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/744218/000110465919027513/0001104659-19-027513-index.htm
2019-06-208-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/744218/000110465919036671/0001104659-19-036671-index.htm
2019-06-21S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/744218/000110465919036997/0001104659-19-036997-index.htm
2019-06-21S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/744218/000110465919037010/0001104659-19-037010-index.htm
2019-06-248-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/744218/000110465919037195/0001104659-19-037195-index.htm
2019-07-083Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/744218/000110465919039565/0001104659-19-039565-index.htm
2019-08-0710-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/744218/000110465919044531/0001104659-19-044531-index.htm
2019-11-1210-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/744218/000110465919062181/0001104659-19-062181-index.htm
2020-03-27424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/744218/000110465920039253/0001104659-20-039253-index.htm
2020-05-0610-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/744218/000110465920057436/0001104659-20-057436-index.htm
2020-06-12S-3/ARegistration statement under Securities Act of 1933https://www.sec.gov/Archives/edgar/data/744218/000110465920072503/0001104659-20-072503-index.htm
2020-06-12CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/744218/000110465920072779/0001104659-20-072779-index.htm
2020-06-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/744218/000110465920072934/0001104659-20-072934-index.htm
2020-06-158-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/744218/000110465920073386/0001104659-20-073386-index.htm
2020-06-15S-3MEFRegistration adding securities to prior Form S-3 registration [Rule 462(b)]https://www.sec.gov/Archives/edgar/data/744218/000110465920073505/0001104659-20-073505-index.htm
2020-06-178-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/744218/000110465920073843/0001104659-20-073843-index.htm
2020-06-188-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/744218/000110465920074646/0001104659-20-074646-index.htm
2020-06-26S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/744218/000110465920077437/0001104659-20-077437-index.htm
2020-08-0610-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/744218/000110465920091459/0001104659-20-091459-index.htm
2020-08-188-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/744218/000110465920096505/0001104659-20-096505-index.htm
2020-11-0510-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/744218/000110465920121786/0001104659-20-121786-index.htm
2020-11-06S-3ASRAutomatic shelf registration statement of securities of well-known seasoned issuershttps://www.sec.gov/Archives/edgar/data/744218/000110465920122483/0001104659-20-122483-index.htm
2020-11-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/744218/000110465920122521/0001104659-20-122521-index.htm
2018-03-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/744218/000117184318001754/0001171843-18-001754-index.htm
2018-04-168-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/744218/000117184318002723/0001171843-18-002723-index.htm
2018-05-108-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/744218/000117184318003787/0001171843-18-003787-index.htm
2018-08-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/744218/000117184318005867/0001171843-18-005867-index.htm
2018-11-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/744218/000117184318007706/0001171843-18-007706-index.htm
2019-03-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/744218/000117184319001578/0001171843-19-001578-index.htm
2019-05-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/744218/000117184319003062/0001171843-19-003062-index.htm
2019-08-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/744218/000117184319005251/0001171843-19-005251-index.htm
2019-11-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/744218/000117184319007429/0001171843-19-007429-index.htm
2020-03-268-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/744218/000117184320002037/0001171843-20-002037-index.htm
2020-05-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/744218/000117184320003372/0001171843-20-003372-index.htm
2020-08-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/744218/000117184320005651/0001171843-20-005651-index.htm
2020-11-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/744218/000117184320007664/0001171843-20-007664-index.htm
2018-03-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/744218/000117911018003192/0001179110-18-003192-index.htm
2018-04-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/744218/000117911018005108/0001179110-18-005108-index.htm
2018-05-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/744218/000117911018006035/0001179110-18-006035-index.htm
2018-06-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/744218/000117911018007858/0001179110-18-007858-index.htm
2018-06-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/744218/000117911018008556/0001179110-18-008556-index.htm
2018-06-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/744218/000117911018008557/0001179110-18-008557-index.htm
2018-06-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/744218/000117911018008558/0001179110-18-008558-index.htm
2018-06-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/744218/000117911018008559/0001179110-18-008559-index.htm
2018-06-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/744218/000117911018008560/0001179110-18-008560-index.htm
2018-06-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/744218/000117911018008561/0001179110-18-008561-index.htm
2018-06-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/744218/000117911018008562/0001179110-18-008562-index.htm
2018-06-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/744218/000117911018008563/0001179110-18-008563-index.htm
2018-06-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/744218/000117911018008564/0001179110-18-008564-index.htm
2018-06-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/744218/000117911018008565/0001179110-18-008565-index.htm
2018-06-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/744218/000117911018008566/0001179110-18-008566-index.htm
2018-06-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/744218/000117911018008567/0001179110-18-008567-index.htm
2018-06-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/744218/000117911018008568/0001179110-18-008568-index.htm
2018-06-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/744218/000117911018008569/0001179110-18-008569-index.htm
2018-06-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/744218/000117911018008570/0001179110-18-008570-index.htm
2018-06-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/744218/000117911018008669/0001179110-18-008669-index.htm
2018-07-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/744218/000117911018009240/0001179110-18-009240-index.htm
2018-08-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/744218/000117911018010087/0001179110-18-010087-index.htm
2018-08-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/744218/000117911018010938/0001179110-18-010938-index.htm
2018-10-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/744218/000117911018011797/0001179110-18-011797-index.htm
2018-11-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/744218/000117911018012450/0001179110-18-012450-index.htm
2018-12-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/744218/000117911018013378/0001179110-18-013378-index.htm
2019-06-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/744218/000117911019007967/0001179110-19-007967-index.htm
2019-06-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/744218/000117911019007968/0001179110-19-007968-index.htm
2019-06-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/744218/000117911019007969/0001179110-19-007969-index.htm
2019-06-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/744218/000117911019007970/0001179110-19-007970-index.htm
2019-06-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/744218/000117911019007971/0001179110-19-007971-index.htm
2019-06-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/744218/000117911019007972/0001179110-19-007972-index.htm
2019-06-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/744218/000117911019007973/0001179110-19-007973-index.htm
2019-06-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/744218/000117911019007974/0001179110-19-007974-index.htm
2019-06-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/744218/000117911019007975/0001179110-19-007975-index.htm
2019-06-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/744218/000117911019007976/0001179110-19-007976-index.htm
2019-06-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/744218/000117911019007977/0001179110-19-007977-index.htm
2019-06-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/744218/000117911019007978/0001179110-19-007978-index.htm
2019-06-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/744218/000117911019007979/0001179110-19-007979-index.htm
2019-07-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/744218/000117911019008540/0001179110-19-008540-index.htm
2020-06-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/744218/000117911020007163/0001179110-20-007163-index.htm
2020-06-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/744218/000117911020007164/0001179110-20-007164-index.htm
2020-06-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/744218/000117911020007165/0001179110-20-007165-index.htm
2020-06-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/744218/000117911020007166/0001179110-20-007166-index.htm
2020-06-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/744218/000117911020007167/0001179110-20-007167-index.htm
2020-06-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/744218/000117911020007218/0001179110-20-007218-index.htm
2020-06-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/744218/000117911020007242/0001179110-20-007242-index.htm
2020-06-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/744218/000117911020007585/0001179110-20-007585-index.htm
2020-06-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/744218/000117911020007586/0001179110-20-007586-index.htm
2020-06-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/744218/000117911020007587/0001179110-20-007587-index.htm
2020-06-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/744218/000117911020007588/0001179110-20-007588-index.htm
2020-06-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/744218/000117911020007589/0001179110-20-007589-index.htm
2020-06-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/744218/000117911020007590/0001179110-20-007590-index.htm
2020-06-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/744218/000117911020007591/0001179110-20-007591-index.htm
2020-06-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/744218/000117911020007592/0001179110-20-007592-index.htm
2020-06-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/744218/000117911020007593/0001179110-20-007593-index.htm
2020-06-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/744218/000117911020007594/0001179110-20-007594-index.htm
2020-06-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/744218/000117911020007595/0001179110-20-007595-index.htm
2020-06-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/744218/000117911020007596/0001179110-20-007596-index.htm
2020-06-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/744218/000117911020007597/0001179110-20-007597-index.htm
2020-06-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/744218/000117911020007598/0001179110-20-007598-index.htm
2018-09-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/744218/000118248918000319/0001182489-18-000319-index.htm
2018-02-13SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/744218/000119312518041541/0001193125-18-041541-index.htm
2019-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/744218/000119312519039738/0001193125-19-039738-index.htm
2020-06-18SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/744218/000119312520171962/0001193125-20-171962-index.htm
2020-06-19SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/744218/000149315220011453/0001493152-20-011453-index.htm
2020-06-12EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/744218/999999999520001412/9999999995-20-001412-index.htm
2018-04-20CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/744218/999999999718005092/9999999997-18-005092-index.htm

Celldex Therapeutics, Inc (CLDX) Insider Transactions:

Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Celldex Therapeutics, Inc (CLDX). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
Insider Ownership: 16%
Institutional Ownership: 8207%

Transaction Date Insider Name Insider Title Type Shares Number Shares Price Total Transaction Shares Held After Transaction Link
2020-06-09Margo Heath-ChiozziSVP of Regulatory AffairsBuy1,000.003.013,005.001,000.00https://www.sec.gov/Archives/edgar/data/744218/000117911020007167/0001179110-20-007167-index.htm
2020-06-09Samuel Bates MartinSVP and CFOBuy9,750.003.0529,737.5010,735.00https://www.sec.gov/Archives/edgar/data/744218/000117911020007166/0001179110-20-007166-index.htm
2020-06-09JAMES J MARINODirectorBuy8,305.003.0024,915.0012,704.00https://www.sec.gov/Archives/edgar/data/744218/000117911020007165/0001179110-20-007165-index.htm
2020-06-10Sarah CavanaughSVP of Corp Affairs & Admin.Buy1,050.004.835,071.501,367.00https://www.sec.gov/Archives/edgar/data/744218/000117911020007218/0001179110-20-007218-index.htm
2020-06-09Anthony S MarucciPresident & CEOBuy15,000.003.0645,900.0019,438.00https://www.sec.gov/Archives/edgar/data/744218/000117911020007163/0001179110-20-007163-index.htm
2020-06-11Diane C. YoungSVP, Chief Medical OfficerBuy2,115.004.7310,003.952,115.00https://www.sec.gov/Archives/edgar/data/744218/000117911020007242/0001179110-20-007242-index.htm
2018-06-15TIBOR KELERExecutive VP & CSOBuy16,500.000.599,782.8535,368.00https://www.sec.gov/Archives/edgar/data/744218/000117911018008669/0001179110-18-008669-index.htm
2018-08-24JAMES J MARINODirectorBuy40,000.000.4819,200.0065,997.00https://www.sec.gov/Archives/edgar/data/744218/000117911018010938/0001179110-18-010938-index.htm
2020-06-09TIBOR KELERExecutive VP & CSOBuy5,000.002.9914,954.007,357.00https://www.sec.gov/Archives/edgar/data/744218/000117911020007164/0001179110-20-007164-index.htm